• Investing
  • Stock
  • Editor’s Pick
  • Economy
The Significant Deals
Stock

Health advocates press Cepheid for cheaper mpox tests

by November 15, 2024
written by November 15, 2024

By Jennifer Rigby

LONDON (Reuters) – Global health advocates have written to the makers of a key mpox diagnostic test to call for its price to be cut from around $20 per test to $5, to help tackle low testing rates in poorer countries badly hit by the virus.

Medical (TASE:PMCN) diagnostics firm Cepheid’s GeneXpert mpox test is one of three approved for emergency use by the World Health Organization, but the price is prohibitive for countries like the hardest-hit Democratic Republic of Congo, activists said.

Mpox was declared a global public health emergency by the WHO this summer, when an outbreak in Congo began to spread to neighbouring countries. The virus typically causes flu-like symptoms and pus-filled lesions and can kill.

This week, WHO said cases in Africa showed a “general rising trend” although they may be levelling off in parts of Congo. But a lack of tests is hindering the capacity to confirm cases, particularly in Congo, one of the world’s poorest countries.

“We urge you to lower the price of the mpox test cartridges to $5 and prioritize supply for African countries fighting mpox outbreaks,” read the letter sent by groups including rights NGO Public Citizen and medical charity Medecins Sans Frontieres.

Cepheid’s test is particularly important because machines that process the results are available across Africa, as they are also used for tuberculosis testing.

Danaher (NYSE:DHR), the parent company of Cepheid, reduced its TB test prices to $7.97 last year after pressure from activists. The companies did not immediately respond to a request for comment.

The $5 price tag proposed by advocates is based on research showing that the tests can be produced for less than that.

Public Citizen’s access to medicines director Peter Maybarduk said the recent WHO approval was an opportunity to ramp up testing. “Lower prices would help health agencies meet the moment,” he said.

This post appeared first on investing.com
0 comment
0
FacebookTwitterPinterestEmail

previous post
Taiwan stocks lower at close of trade; Taiwan Weighted down 0.63%
next post
Japan stocks higher at close of trade; Nikkei 225 up 0.35%

You may also like

BASF results down on impairments, restructuring

January 27, 2025

European chipmakers slump as traders gauge DeepSeek AI...

January 27, 2025

Nasdaq futures tumble as China’s AI push rattles...

January 27, 2025

China Vanke’s CEO, chairman resign amid growing liquidity...

January 27, 2025

Fuji Media, rocked by sexual misconduct allegations, says...

January 27, 2025

Italy’s MPS shares fall ahead of Mediobanca board...

January 27, 2025

British Land stock drops following stake sale

January 27, 2025

UMG shares rally after new multi-year pact with...

January 27, 2025

BASF shares indicated 3% lower as impairments drag...

January 27, 2025

Ryanair cuts 2026 traffic forecast amid ongoing Boeing...

January 27, 2025
Fill Out & Get More Relevant News








    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Recent Posts

    • Procter & Gamble to cut 7,000 jobs as part of broader restructuring

      June 6, 2025
    • Shein and Temu see U.S. demand plunge as loophole for cheap goods closes

      June 6, 2025
    • Shein and Temu see U.S. demand plunge as loophole for cheap goods closes

      June 5, 2025
    • This California startup is cleaning water and removing CO₂ from the atmosphere — all at a reduced cost

      June 5, 2025

    Categories

    • Economy (245)
    • Editor's Pick (3,646)
    • Investing (504)
    • Stock (6,426)

    Latest News

    • Procter & Gamble to cut 7,000 jobs as part of broader restructuring
    • Shein and Temu see U.S. demand plunge as loophole for cheap goods closes

    Popular News

    • Brazil’s 2024 growth seen at 3.6%, fiscal target met, says finance minister
    • ASML shares rise as analysts cheer guidance for sales growth through 2030

    About The Significant deals

    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 thesignificantdeals.com | All Rights Reserved

    The Significant Deals
    • Investing
    • Stock
    • Editor’s Pick
    • Economy